Quick answer: For men over 40, the peptides that get discussed fall into a few groups: growth-hormone secretagogues (sermorelin, ipamorelin, CJC-1295), tissue-repair compounds (BPC-157, TB-500), and hormone-axis peptides (gonadorelin, tesamorelin). Most are not FDA-approved for anti-aging or testosterone support, and their compounding status changed repeatedly in 2024 through 2026. If your real goal is the energy, body composition, and hormone health that decline after 40, the most evidence-backed and legally available starting point is a physician-supervised GLP-1 program for losing visceral fat. FormBlends offers clinician-supervised compounded semaglutide and tirzepatide for eligible weight-management patients. See /products/semaglutide or compare options at /tools/provider-comparison.
Testosterone falls roughly 1 to 2 percent per year in men after about age 30, and growth hormone output drops with each decade (Harman et al., J Clin Endocrinol Metab, 2001). That shows up as slower recovery, lost muscle, stubborn belly fat, and flat energy. Peptides get marketed as the fix. Some have real science behind the mechanism. Most lack the human trials to back the bigger claims, and the legal status has been a moving target.
Which peptides do men over 40 look at?
Answer: the short list is sermorelin, ipamorelin, CJC-1295, BPC-157, TB-500, PT-141, tesamorelin, and gonadorelin. Here is what each does and where the evidence and legality stand in 2026.
Growth-hormone secretagogues (sermorelin, ipamorelin, CJC-1295)
These tell your pituitary to release more of your own growth hormone instead of injecting GH directly. Sermorelin is a fragment of growth-hormone-releasing hormone. Ipamorelin is a selective ghrelin-receptor agonist that raises GH without spiking cortisol or prolactin. CJC-1295 is a longer-acting GHRH analog often paired with ipamorelin. The mechanisms are documented. What is thin is long-term human outcome data in healthy men over 40. None is FDA-approved for anti-aging. Ipamorelin and CJC-1295 were placed in FDA Category 2 in 2023, then removed in September 2024 after their nominations were withdrawn. Removal does not mean approval, and access still depends on further FDA review.
Tissue-repair peptides (BPC-157, TB-500)
BPC-157 is a synthetic 15-amino-acid sequence based on a protein in gastric juice. TB-500 is a synthetic thymosin beta-4. Animal studies show both speed healing of tendon, muscle, and gut tissue. Human trials are essentially absent. BPC-157 was in FDA Category 2 from 2023 and was removed on April 22, 2026, ahead of a Pharmacy Compounding Advisory Committee review set for July 2026. It is still not FDA-approved, and products sold online as "research grade" remain unregulated.
Hormone-axis peptides (gonadorelin, tesamorelin)
Gonadorelin is synthetic gonadotropin-releasing hormone. It can stimulate the testosterone pathway and preserve testicular function, which direct testosterone therapy suppresses. Tesamorelin is the one genuinely FDA-approved peptide here, cleared to reduce visceral fat in HIV-associated lipodystrophy. Use in healthy men is off-label.
PT-141 (bremelanotide)
PT-141 (bremelanotide) acts on melanocortin receptors in the brain to affect sexual desire. Bremelanotide is FDA-approved as Vyleesi for premenopausal women; use in men is off-label and not FDA-approved.
What is the best peptide for testosterone in men over 40?
Answer: no peptide is FDA-approved to raise testosterone. Gonadorelin has the most plausible mechanism, stimulating luteinizing hormone to support the body's own testosterone production while preserving fertility. But it requires frequent dosing and is not a proven anti-aging therapy. If low testosterone is documented on bloodwork, the established options are clinician-supervised testosterone therapy or treating the upstream drivers, especially excess weight. Visceral fat lowers testosterone, so fat loss often raises it.
What is the safest way for a man over 40 to start?
Answer: start with what is approved, measured, and supervised. The biggest lever for energy, body composition, and hormone health after 40 is usually losing visceral fat, and GLP-1 medication is the most studied tool for that. In the drug class studied in the STEP 1 trial, semaglutide produced an average weight loss of 14.9 percent of body weight over 68 weeks. In the drug class studied in the SURMOUNT-1 trial, tirzepatide reached an average of about 20.9 to 22.5 percent at the 15 mg dose over 72 weeks. That is trial-grade evidence, more than almost any anti-aging peptide can claim. FormBlends offers clinician-supervised compounded semaglutide and tirzepatide for eligible patients prioritizing weight and metabolic health. Compare at /tools/provider-comparison.
From the FormBlends catalog
Longevity Reset
Telomere support with the master antioxidant. · Bundle from $253 · provider-reviewed peptide bundle.
View Longevity Reset →Do these peptides require a prescription?
Answer: yes, and access depends on shifting FDA rules. Tesamorelin is a prescription FDA-approved drug. The growth-hormone secretagogues and repair peptides are not approved for these uses. Their compounding status changed in 2024 and 2026, but removal from Category 2 is not the same as approval. Products sold without a prescription as supplements or "research chemicals" sit outside FDA oversight, with no guarantee of identity, purity, or dose.
Peptide overview table
| Peptide | Marketed use | Evidence level | 2026 FDA status | Sold by FormBlends |
|---|---|---|---|---|
| Sermorelin | GH support, sleep | Mechanism documented, limited outcomes | Not approved for anti-aging | No |
| Ipamorelin | GH support | Mechanism documented, limited outcomes | Removed from Category 2 (Sep 2024), not approved | No |
| CJC-1295 | Muscle, GH | Limited human data | Removed from Category 2 (Sep 2024), not approved | No |
| BPC-157 | Tissue repair | Animal data only | Removed from Category 2 (Apr 2026), PCAC review pending, not approved | No |
| TB-500 | Tissue repair | Animal data only | Placed in Category 2 (2023), not approved | No |
| PT-141 | Sexual function | Approved in women (Vyleesi) | Off-label in men | No |
| Tesamorelin | Visceral fat | Approved for HIV lipodystrophy | FDA-approved, narrow indication | No |
| Gonadorelin | Testosterone axis | Mechanism documented | Diagnostic approval, off-label use | No |
How long until peptides work?
Answer: it depends on the compound and goal, and for most anti-aging uses there is no reliable human timeline because the trials do not exist. By contrast, GLP-1 weight-loss medication has clear data: appetite changes appear within weeks and meaningful weight loss accumulates over months in the published trials.
Frequently asked questions
Are peptides safe for long-term use in men over 40? Long-term human safety data is limited for most peptides discussed here, which is why the FDA flagged several in 2023. The only one with an established safety record in its approved use is tesamorelin, for a narrow indication.
Can peptides replace testosterone replacement therapy? No peptide is approved to replace testosterone therapy. Gonadorelin can support the natural pathway in some men with secondary hypogonadism, but men with primary testicular failure need direct treatment. This is a physician decision based on bloodwork.
Do I need a prescription for these peptides? Yes, where they are legally available. Their compounding status has changed, so confirm current legality with a licensed provider rather than buying from online "research" suppliers.
Are peptides sold over the counter for men? Products marketed over the counter as "peptides" are supplements, not the prescription compounds in clinical research, and are not regulated for these uses.
What is the best peptide for vitality and energy in men over 40? There is no approved peptide for vitality. The most evidence-backed move for energy after 40 is correcting the drivers: sleep, training, and visceral fat. GLP-1 therapy addresses the fat-loss piece with trial-grade data.
What does FormBlends actually offer? FormBlends is a physician-supervised telehealth program that prescribes compounded semaglutide and tirzepatide. It does not sell BPC-157, sermorelin, or other peptides. For weight and metabolic health, it is one option to compare. See /products/semaglutide.
Is BPC-157 legal to buy in 2026? BPC-157 was removed from FDA Category 2 in April 2026, but it is still not FDA-approved and a PCAC review is pending. Products sold online remain unregulated.
Should men over 40 stack multiple peptides? Stacking unapproved compounds multiplies unknown risk. Start with approved, supervised options before considering anything experimental, and only with a physician.
Sources
- Harman SM, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001. https://pubmed.ncbi.nlm.nih.gov/11158037/
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- U.S. FDA. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
- U.S. FDA. Bulk Drug Substances Used in Compounding Under Section 503A. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →
